{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["drug delivery", "exosomes", "nanoparticles", "natural compound", "neoplasms"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38491817", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "18"}, "Article": {"Language": ["eng"], "ELocationID": ["e7010", "10.1002/cam4.7010"], "ArticleDate": [], "Journal": {"ISSN": "2045-7634", "JournalIssue": {"Volume": "13", "Issue": "5", "PubDate": {"Year": "2024", "Month": "Mar"}}, "Title": "Cancer medicine", "ISOAbbreviation": "Cancer Med"}, "ArticleTitle": "Integrating natural compounds and nanoparticle-based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy.", "Pagination": {"StartPage": "e7010", "MedlinePgn": "e7010"}, "Abstract": {"AbstractText": ["Cancer remains a leading cause of death worldwide, necessitating the development of innovative and more effective treatment strategies. Conventional cancer treatments often suffer from limitations such as systemic toxicity, poor pharmacokinetics, and drug resistance. Recently, there has been growing attention to utilizing natural compounds derived from various sources as possible cancer therapeutics. Natural compounds have demonstrated diverse bioactive properties, including antioxidant, anti-inflammatory, and antitumor effects, making them attractive candidates for cancer treatment. However, their limited solubility and bioavailability present challenges for effective delivery to cancer cells. To overcome these limitations, researchers have turned to nanotechnology-based drug delivery systems. Nanoparticles, with their small size and unique properties, can encapsulate therapeutic agents and offer benefits such as improved solubility, prolonged drug release, enhanced cellular uptake, and targeted delivery. Functionalizing nanoparticles with specific ligands further enhances their precision in recognizing and binding to cancer cells. Combining natural compounds with nanotechnology holds great promise in achieving efficient and safe cancer treatments by enhancing bioavailability, pharmacokinetics, and selectivity toward cancer cells. This review article provides an overview of the advancements in utilizing natural substances and nanotechnology-based drug delivery systems for cancer treatment. It discusses the benefits and drawbacks of various types of nanoparticles, as well as the characteristics of natural compounds that make them appealing for cancer therapy. Additionally, current research on natural substances and nanoparticles in preclinical and clinical settings is highlighted. Finally, the challenges and future perspectives in developing natural compound-nanoparticle-based cancer therapies are discussed."], "CopyrightInformation": "\u00a9 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of biology faculty of science, Ferdowsi University of Mashhad, Mashhad, Iran."}], "LastName": "Manzari-Tavakoli", "ForeName": "Asma", "Initials": "A"}, {"Identifier": ["0000-0002-8853-4343"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Oncopathology Research Center, Department of Molecular Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Babajani", "ForeName": "Amirhesam", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Tavakoli", "ForeName": "Maryam Manzari", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Safaeinejad", "ForeName": "Fahimeh", "Initials": "F"}, {"Identifier": ["0000-0002-8165-5978"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Jafari", "ForeName": "Ameneh", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cancer Med", "NlmUniqueID": "101595310", "ISSNLinking": "2045-7634"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Nanoparticle Drug Delivery System"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Nanoparticle Drug Delivery System"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}], "CoiStatement": "None declared."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sung H, Ferlay J, Siegel RL, et\u00a0al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u2010249.", "ArticleIdList": ["33538338"]}, {"Citation": "Kumar G, Virmani T, Sharma A, Pathak K. Codelivery of phytochemicals with conventional anticancer drugs in form of nanocarriers. Pharmaceutics. 2023;15(3):889.", "ArticleIdList": ["PMC10055866", "36986748"]}, {"Citation": "Babajani A, Soltani P, Jamshidi E, Farjoo MH, Niknejad H. Recent Advances on Drug\u2010Loaded Mesenchymal Stem Cells With Anti\u2010neoplastic Agents for Targeted Treatment of Cancer. Front Mol Biosci. 2020;8. 10.3389/fbioe.2020.00748", "ArticleIdList": ["10.3389/fbioe.2020.00748", "PMC7390947", "32793565"]}, {"Citation": "Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti\u2010cancer agents. Chem Rev. 2009;109(7):3012\u20103043.", "ArticleIdList": ["19422222"]}, {"Citation": "Ezzati M, Yousefi B, Velaei K, Safa A. A review on anti\u2010cancer properties of quercetin in breast cancer. Life Sci. 2020;248:117463.", "ArticleIdList": ["32097663"]}, {"Citation": "Parisi OI, Puoci F, Restuccia D, Farina G, Iemma F, Picci N. Polyphenols and their formulations: different strategies to overcome the drawbacks associated with their poor stability and bioavailability. Polyphenol Human Heal Dis. 2014;29\u201045."}, {"Citation": "Mousavi SM, Hosseindoost S, Mahdian SMA, et\u00a0al. Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells. Pathology\u2010Research and Practice. 2023;245:154427.", "ArticleIdList": ["37028110"]}, {"Citation": "Jafari A, Niknam Z, Rahimi M, Zali H, Rezaei\u2010Tavirani M. Silver nanoparticles inhibit proliferation and migration of prostate cancer cells: an experimental report. World Canc Res J. 2022;9:e2242."}, {"Citation": "Yan L, Shen J, Wang J, Yang X, Dong S, Lu S. Nanoparticle\u2010based drug delivery system: a patient\u2010friendly chemotherapy for oncology. Dose\u2010Response. 2020;18(3):1559325820936161.", "ArticleIdList": ["PMC7357073", "32699536"]}, {"Citation": "Jafari A, Tabaei SS, Rahimi M, Taranejoo S, Ghanimatdan M. Herbal extract incorporated chitosan based nanofibers as a new strategy for smart anticancer drug delivery system: an in\u00a0vitro model. World Canc Res J. 2020;7:11."}, {"Citation": "Babajani A, Manzari\u2010Tavakoli A, Jamshidi E, Tarasi R, Niknejad H. Anti\u2010cancer effects of human placenta\u2010derived amniotic epithelial stem cells loaded with paclitaxel on cancer cells. Sci Rep. 2022;12(1):18148.", "ArticleIdList": ["PMC9616866", "36307463"]}, {"Citation": "Zare M, Norouzi Roshan Z, Assadpour E, Jafari SM. Improving the cancer prevention/treatment role of carotenoids through various nano\u2010delivery systems. Crit Rev Food Sci Nutr. 2021;61(3):522\u2010534.", "ArticleIdList": ["32180434"]}, {"Citation": "Yao Y, Zhou Y, Liu L, et\u00a0al. Nanoparticle\u2010based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci. 2020;7:193.", "ArticleIdList": ["PMC7468194", "32974385"]}, {"Citation": "Patra JK, Das G, Fraceto LF, et\u00a0al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71.", "ArticleIdList": ["PMC6145203", "30231877"]}, {"Citation": "Din FU, Aman W, Ullah I, et\u00a0al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 2017;12:7291\u20107309.", "ArticleIdList": ["PMC5634382", "29042776"]}, {"Citation": "Rahim MA, Jan N, Khan S, et\u00a0al. Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting. Cancers (Basel). 2021;13(4):670.", "ArticleIdList": ["PMC7914759", "33562376"]}, {"Citation": "Bhattacharjee S. Craft of co\u2010encapsulation in nanomedicine: a struggle to achieve synergy through reciprocity. ACS Pharmacol Trans Sci. 2022;5(5):278\u2010298.", "ArticleIdList": ["PMC9112416", "35592431"]}, {"Citation": "Fulton MD, Najahi\u2010Missaoui W. Liposomes in cancer therapy: how did we start and where are we now. Int J Mol Sci. 2023;24(7):6615.", "ArticleIdList": ["PMC10095497", "37047585"]}, {"Citation": "Repp L, Skoczen SL, Rasoulianboroujeni M, Stern ST, Kwon GS. Plasma stability and plasma metabolite concentration\u2013time profiles of oligo(lactic acid)8\u2010paclitaxel prodrug loaded polymeric micelles. AAPS J. 2023;25(3):39.", "ArticleIdList": ["PMC10141660", "37041376"]}, {"Citation": "Zhang H. Onivyde for the therapy of multiple solid tumors. Onco Targets Ther. 2016;9:3001\u20103007.", "ArticleIdList": ["PMC4881920", "27284250"]}, {"Citation": "Dehelean CA, Marcovici I, Soica C, et\u00a0al. Plant\u2010derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules. 2021;26(4):1109.", "ArticleIdList": ["PMC7922180", "33669817"]}, {"Citation": "Ghosh S, Sarkar T, Pati S, Kari ZA, Edinur HA, Chakraborty R. Novel bioactive compounds from marine sources as a tool for functional food development. Frontiers in marine. Science. 2022;9:9."}, {"Citation": "George BP, Chandran R, Abrahamse H. Role of phytochemicals in cancer chemoprevention: insights. Antioxidants (Basel). 2021;10(9):1455.", "ArticleIdList": ["PMC8466984", "34573087"]}, {"Citation": "Davoodvandi A, Sadeghi S, Alavi SMA, et\u00a0al. The therapeutic effects of berberine for gastrointestinal cancers. Asia Pac J Clin Oncol. 2023;1\u201016. 10.1111/ajco.13941", "ArticleIdList": ["10.1111/ajco.13941", "36915942"]}, {"Citation": "Ali Abdalla YO, Subramaniam B, Nyamathulla S, et\u00a0al. Natural products for cancer therapy: a review of their mechanism of actions and toxicity in the past decade. J Trop Med. 2022;2022:5794350.", "ArticleIdList": ["PMC8933079", "35309872"]}, {"Citation": "Kumari A, Singla R, Guliani A, Yadav SK. Nanoencapsulation for drug delivery. Excli J. 2014;13:265\u2010286.", "ArticleIdList": ["PMC4464443", "26417260"]}, {"Citation": "Bajracharya R, Song JG, Patil BR, et\u00a0al. Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems. Drug Deliv. 2022;29(1):1959\u20101970.", "ArticleIdList": ["PMC9246174", "35762636"]}, {"Citation": "Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3:7.", "ArticleIdList": ["PMC5854578", "29560283"]}, {"Citation": "Idham Z, Putra NR, Aziz AHA, et\u00a0al. Improvement of extraction and stability of anthocyanins, the natural red pigment from roselle calyces using supercritical carbon dioxide extraction. J CO2 Utilization. 2022;56:101839."}, {"Citation": "Rosales TKO, Fabi JP. Nanoencapsulated anthocyanin as a functional ingredient: technological application and future perspectives. Colloids Surf. B Biointerfaces. 2022;218:112707.", "ArticleIdList": ["35907354"]}, {"Citation": "Oladzadabbasabadi N, Nafchi AM, Ghasemlou M, Ariffin F, Singh Z, Al\u2010Hassan A. Natural anthocyanins: sources, extraction, characterization, and suitability for smart packaging. Food Packag Shelf Life. 2022;33:100872."}, {"Citation": "Baster Z, Li L, Kukkurainen S, et\u00a0al. Cyanidin\u20103\u2010glucoside binds to talin and modulates colon cancer cell adhesions and 3D growth. FASEB J. 2020;34(2):2227\u20102237.", "ArticleIdList": ["31916632"]}, {"Citation": "Urias\u2010Lugo DA, Heredia JB, Muy\u2010Rangel MD, Valdez\u2010Torres JB, Serna\u2010Sald\u00edvar S, Gutierrez\u2010Uribe JA. Anthocyanins and phenolic acids of hybrid and native blue maize (Zea mays L.) extracts and their antiproliferative activity in mammary (MCF7), liver (HepG2), colon (Caco2 and HT29) and prostate (PC3) cancer cells. Plant Foods Hum Nutr. 2015;70(2):193\u2010199.", "ArticleIdList": ["25762472"]}, {"Citation": "Bars\u2010Cortina D, Sakhawat A, Pi\u00f1ol\u2010Felis C, Motilva M\u2010J. Chemopreventive effects of anthocyanins on colorectal and breast cancer: a review. Seminars in Cancer Biology. Elsevier; 2021.", "ArticleIdList": ["33359264"]}, {"Citation": "Mottaghipisheh J, Doustimotlagh AH, Irajie C, Tanideh N, Barzegar A, Iraji A. The promising therapeutic and preventive properties of anthocyanidins/anthocyanins on prostate cancer. Cell. 2022;11(7):1070.", "ArticleIdList": ["PMC8997497", "35406634"]}, {"Citation": "Guo L, Jin Y, Yang Y, et\u00a0al. Calcicoptosis induced by purple sweet potato anthocyanins through the nonosmotic regulation of the NFAT5/S100A4\u2010S100A9 pathway in acute lymphoblastic leukemia. Chem Biodivers. 2022;19(9):e202200447.", "ArticleIdList": ["35924786"]}, {"Citation": "Alsharairi NA. Insights into the mechanisms of action of proanthocyanidins and anthocyanins in the treatment of nicotine\u2010induced non\u2010small cell lung cancer. Int J Mol Sci. 2022;23(14):7905.", "ArticleIdList": ["PMC9316101", "35887251"]}, {"Citation": "Diaconeasa Z, \u0218tirbu I, Xiao J, et\u00a0al. Anthocyanins, vibrant color pigments, and their role in skin cancer prevention. Biomedicine. 2020;8(9):336.", "ArticleIdList": ["PMC7555344", "32916849"]}, {"Citation": "Munagala R, Aqil F, Jeyabalan J, et\u00a0al. Exosomal formulation of anthocyanidins against multiple cancer types. Cancer Lett. 2017;393:94\u2010102.", "ArticleIdList": ["PMC5837866", "28202351"]}, {"Citation": "Hamedi S, Koosha M. Designing a pH\u2010responsive drug delivery system for the release of black\u2010carrot anthocyanins loaded in halloysite nanotubes for cancer treatment. Appl Clay Sci. 2020;197:105770."}, {"Citation": "Jafari A, Babajani A, Abdollahpour\u2010Alitappeh M, Ahmadi N, Rezaei\u2010Tavirani M. Exosomes and cancer: from molecular mechanisms to clinical applications. Med Oncol. 2021;38(4). 10.1007/s12032-021-01491-0", "ArticleIdList": ["10.1007/s12032-021-01491-0", "33743101"]}, {"Citation": "Thibado SP, Thornthwaite JT, Ballard TK, Goodman BT. Anticancer effects of bilberry anthocyanins compared with NutraNanoSphere encapsulated bilberry anthocyanins. Mol Clin Oncol. 2018;8(2):330\u2010335.", "ArticleIdList": ["PMC5774531", "29399357"]}, {"Citation": "Xu C, Wang Y, Yu H, Tian H, Chen X. Multifunctional theranostic nanoparticles derived from fruit\u2010extracted anthocyanins with dynamic disassembly and elimination abilities. ACS Nano. 2018;12(8):8255\u20108265.", "ArticleIdList": ["30088914"]}, {"Citation": "Mudd AM, Gu T, Munagala R, Jeyabalan J, Egilmez NK, Gupta RC. Chemoprevention of colorectal cancer by anthocyanidins and mitigation of metabolic shifts induced by dysbiosis of the gut MicrobiomeAnthos prevent metabolic shifts from microbiome and B [a] P. Cancer Prev res. 2020;13(1):41\u201052.", "ArticleIdList": ["PMC6954290", "31796466"]}, {"Citation": "Xiong Y, Yang G, Zhou H, et\u00a0al. A ROS\u2010responsive self\u2010assembly driven by multiple intermolecular interaction enhances tumor\u2010targeted chemotherapy. J Pharm Sci. 2021;110(4):1668\u20101675.", "ArticleIdList": ["33198946"]}, {"Citation": "Aqil F, Jeyabalan J, Agrawal AK, et\u00a0al. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer. Food Funct. 2017;8(11):4100\u20104107.", "ArticleIdList": ["28991298"]}, {"Citation": "Gupta A, Singh AK, Kumar R, Jamieson S, Pandey AK, Bishayee A. Neuroprotective potential of ellagic acid: a critical review. Adv Nut. 2021;12(4):1211\u20101238.", "ArticleIdList": ["PMC8321875", "33693510"]}, {"Citation": "Shakeri A, Zirak MR, Sahebkar A. Ellagic acid: a logical lead for drug development? Curr Pharm des. 2018;24(2):106\u2010122.", "ArticleIdList": ["29141541"]}, {"Citation": "Sharifi\u2010Rad J, Quispe C, Castillo CMS, et\u00a0al. Ellagic acid: a review on its natural sources, chemical stability, and therapeutic potential. Oxid Med Cell Longev. 2022;2022:1\u201024.", "ArticleIdList": ["PMC8885183", "35237379"]}, {"Citation": "Landete J. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food res Int. 2011;44(5):1150\u20101160."}, {"Citation": "Alfei S, Turrini F, Catena S, et\u00a0al. Ellagic acid a multi\u2010target bioactive compound for drug discovery in CNS? A narrative review. Eur J Med Chem. 2019;183:111724.", "ArticleIdList": ["31563012"]}, {"Citation": "Zeb A. Ellagic acid in suppressing in\u00a0vivo and in\u00a0vitro oxidative stresses. Mol Cell Biochem. 2018;448(1):27\u201041.", "ArticleIdList": ["29388153"]}, {"Citation": "Umesalma S, Sudhandiran G. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT\u2010phosphoinositide\u20103 kinase pathway. Eur J Pharmacol. 2011;660(2\u20133):249\u2010258.", "ArticleIdList": ["21463623"]}, {"Citation": "N\u00fa\u00f1ez\u2010S\u00e1nchez M\u00c1, Karmokar A, Gonz\u00e1lez\u2010Sarr\u00edas A, et\u00a0al. In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: a new potentiality for ellagitannin metabolites against cancer. Food Chem Toxicol. 2016;92:8\u201016.", "ArticleIdList": ["26995228"]}, {"Citation": "Qiu Z, Zhou B, Jin L, et\u00a0al. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells. Food Chem Toxicol. 2013;59:428\u2010437.", "ArticleIdList": ["23811531"]}, {"Citation": "Duan J, Li Y, Gao H, et\u00a0al. Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer. Food Funct. 2020;11(7):6332\u20106339.", "ArticleIdList": ["32608435"]}, {"Citation": "Zaazaa AM, Lokman MS, Shalby AB, Ahmed HH, El\u2010Toumy SA. Ellagic acid holds promise against hepatocellular carcinoma in an experimental model: mechanisms of action. Asian Pacific J Canc Prev. 2018;19(2):387\u2010393.", "ArticleIdList": ["PMC5980924", "29479987"]}, {"Citation": "Li L, Wang K, Jia R, et\u00a0al. Ferroportin\u2010dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation. Redox Biol. 2022;56:102435.", "ArticleIdList": ["PMC9425030", "36029649"]}, {"Citation": "Pirzadeh\u2010Naeeni S, Mozdianfard MR, Shojaosadati SA, Khorasani AC, Saleh T. A comparative study on schizophyllan and chitin nanoparticles for ellagic acid delivery in treating breast cancer. Int J Biol Macromol. 2020;144:380\u2010388.", "ArticleIdList": ["31837368"]}, {"Citation": "Ali OM, Bekhit AA, Khattab SN, et\u00a0al. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Colloids Surf B Biointerfaces. 2020;188:110824.", "ArticleIdList": ["32023511"]}, {"Citation": "Malik A, Afaq S, Shahid M, Akhtar K, Assiri A. Influence of ellagic acid on prostate cancer cell proliferation: a caspase\u2013dependent pathway. Asian Pac J Trop Med. 2011;4(7):550\u2010555.", "ArticleIdList": ["21803307"]}, {"Citation": "Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G. Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Eur Urol. 2005;47(4):449\u2010455.", "ArticleIdList": ["15774240"]}, {"Citation": "Wang Y, Ren F, Li B, Song Z, Chen P, Ouyang L. Ellagic acid exerts antitumor effects via the PI3K signaling pathway in endometrial cancer. J Cancer. 2019;10(15):3303\u20103314.", "ArticleIdList": ["PMC6603400", "31293633"]}, {"Citation": "Abdelazeem KN, Singh Y, Lang F, Salker MS. Negative effect of ellagic acid on cytosolic pH regulation and glycolytic flux in human endometrial cancer cells. Cell Physiol Biochem. 2017;41(6):2374\u20102382.", "ArticleIdList": ["28467979"]}, {"Citation": "Kaur H, Ghosh S, Kumar P, Basu B, Nagpal K. Ellagic acid\u2010loaded, tween 80\u2010coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: in\u2010vitro and in\u2010vivo study. Life Sci. 2021;284:119927.", "ArticleIdList": ["34492262"]}, {"Citation": "Ruan J, Yang Y, Yang F, Wan K, Fan D, Wang D. Novel oral administrated ellagic acid nanoparticles for enhancing oral bioavailability and anti\u2010inflammatory efficacy. J Drug Del Sci Tech. 2018;46:215\u2010222."}, {"Citation": "Nyamba I, Lechanteur A, Semd\u00e9 R, Evrard B. Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: a review. Eur J Pharm Biopharm. 2021;159:198\u2010210.", "ArticleIdList": ["33197529"]}, {"Citation": "Wang S\u2010T, Chou C\u2010T, Su N\u2010W. A food\u2010grade self\u2010nanoemulsifying delivery system for enhancing oral bioavailability of ellagic acid. J Funct Foods. 2017;34:207\u2010215."}, {"Citation": "Gonz\u00e1lez\u2010Sarr\u00edas A, Garc\u00eda\u2010Villalba R, N\u00fa\u00f1ez\u2010S\u00e1nchez M\u00c1, et\u00a0al. Identifying the limits for ellagic acid bioavailability: a crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. J Funct Foods. 2015;19:225\u2010235."}, {"Citation": "Mady FM, Shaker MA. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles. Int J Nanomedicine. 2017;12:7405\u20107417.", "ArticleIdList": ["PMC5644528", "29066891"]}, {"Citation": "Dubey A, Park DW, Kwon JE, et\u00a0al. Investigation of the biological and anti\u2010cancer properties of ellagic acid\u2010encapsulated nano\u2010sized metalla\u2010cages. Int J Nanomedicine. 2015;10:227\u2010240.", "ArticleIdList": ["PMC4562765", "26366074"]}, {"Citation": "Arulmozhi V, Pandian K, Mirunalini S. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces. 2013;110:313\u2010320.", "ArticleIdList": ["23732810"]}, {"Citation": "Tian Q, An L, Tian Q, Lin J, Yang S. Ellagic acid\u2010Fe@ BSA nanoparticles for endogenous H2S accelerated Fe (III)/Fe (II) conversion and photothermal synergistically enhanced chemodynamic therapy. Theranostics. 2020;10(9):4101\u20104115.", "ArticleIdList": ["PMC7086347", "32226542"]}, {"Citation": "Koushki M, Amiri\u2010Dashatan N, Ahmadi N, Abbaszadeh HA, Rezaei\u2010Tavirani M. Resveratrol: a miraculous natural compound for diseases treatment. Food Sci Nutr. 2018;6(8):2473\u20102490.", "ArticleIdList": ["PMC6261232", "30510749"]}, {"Citation": "Roshani M, Jafari A, Loghman A, et\u00a0al. Applications of resveratrol in the treatment of gastrointestinal cancer. Biomed Pharmacother. 2022;153:113274.", "ArticleIdList": ["35724505"]}, {"Citation": "Nassir AM, Shahzad N, Ibrahim IA, Ahmad I, Md S, Ain MR. Resveratrol\u2010loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells. Saudi Pharma J. 2018;26(6):876\u2010885.", "ArticleIdList": ["PMC6128707", "30202231"]}, {"Citation": "Wang W, Zhang L, Chen T, et\u00a0al. Anticancer effects of resveratrol\u2010loaded solid lipid nanoparticles on human breast cancer cells. Molecules. 2017;22(11):1814.", "ArticleIdList": ["PMC6150230", "29068422"]}, {"Citation": "Jangid AK, Patel K, Jain P, et\u00a0al. Inulin\u2010pluronic\u2010stearic acid based double folded nanomicelles for pH\u2010responsive delivery of resveratrol. Carbohydr Polym. 2020;247:116730.", "ArticleIdList": ["32829852"]}, {"Citation": "Lin X\u2010M, Shi X\u2010X, Xiong L, et\u00a0al. Construction of IL\u201013 receptor \u03b12\u2010targeting resveratrol nanoparticles against glioblastoma cells: therapeutic efficacy and molecular effects. Int J Mol Sci. 2021;22(19):10622.", "ArticleIdList": ["PMC8508707", "34638961"]}, {"Citation": "Marinheiro D, Ferreira BJ, Oskoei P, Oliveira H, Daniel\u2010da\u2010Silva AL. Encapsulation and enhanced release of resveratrol from mesoporous silica nanoparticles for melanoma therapy. Dent. Mater. 2021;14(6):1382.", "ArticleIdList": ["PMC8000002", "33809119"]}, {"Citation": "El\u2010Melegy MG, Eltaher HM, Gaballah A, El\u2010Kamel AH. Enhanced oral permeability of trans\u2010resveratrol using nanocochleates for boosting anticancer efficacy; in\u2010vitro and ex\u2010vivo appraisal. Eur J Pharm Biopharm. 2021;168:166\u2010183.", "ArticleIdList": ["34481049"]}, {"Citation": "Wang W, Zhou M, Xu Y, et\u00a0al. Resveratrol\u2010loaded TPGS\u2010resveratrol\u2010solid lipid nanoparticles for multidrug\u2010resistant therapy of breast cancer: in\u00a0vivo and in\u00a0vitro study. Front Bioeng Biotechnol. 2021;9:1167.", "ArticleIdList": ["PMC8688991", "34950642"]}, {"Citation": "Gregoriou Y, Gregoriou G, Yilmaz V, et\u00a0al. Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells. Nanotheranostics. 2021;5(1):113\u2010124.", "ArticleIdList": ["PMC7738945", "33391978"]}, {"Citation": "Khayat MT, Zarka MA, El\u2010Telbany DFA, et\u00a0al. Intensification of resveratrol cytotoxicity, pro\u2010apoptosis, oxidant potentials in human colorectal carcinoma HCT\u2010116 cells using zein nanoparticles. Sci Rep. 2022;12(1):15235.", "ArticleIdList": ["PMC9458658", "36075939"]}, {"Citation": "Thipe VC, Panjtan Amiri K, Bloebaum P, et\u00a0al. Development of resveratrol\u2010conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti\u2010tumor efficacy against breast, pancreatic and prostate cancers. Int J Nanomedicine. 2019;4413\u201028:4413\u20104428.", "ArticleIdList": ["PMC6592052", "31417252"]}, {"Citation": "Fan C, Kong F, Shetti D, Zhang B, Yang Y, Wei K. Resveratrol loaded oxidized mesoporous carbon nanoparticles: a promising tool to treat triple negative breast cancer. Biochem Biophys res Commun. 2019;519(2):378\u2010384.", "ArticleIdList": ["31519327"]}, {"Citation": "Hussain T, Paranthaman S, Rizvi SMD, et\u00a0al. Fabrication and characterization of paclitaxel and resveratrol loaded soluplus polymeric nanoparticles for improved BBB penetration for glioma management. Polymers. 2021;13(19):3210.", "ArticleIdList": ["PMC8512154", "34641026"]}, {"Citation": "Al\u2010Jubori AA, Sulaiman GM, Tawfeeq AT, Mohammed HA, Khan RA, Mohammed SA. Layer\u2010by\u2010layer nanoparticles of tamoxifen and resveratrol for dual drug delivery system and potential triple\u2010negative breast cancer treatment. Pharmaceutics. 2021;13(7):1098.", "ArticleIdList": ["PMC8309206", "34371789"]}, {"Citation": "Zheng Y, Jia R, Li J, Tian X, Qian Y. Curcumin\u2010 and resveratrol\u2010co\u2010loaded nanoparticles in synergistic treatment of hepatocellular carcinoma. J Nanobiotechnol. 2022;20(1):339.", "ArticleIdList": ["PMC9301856", "35858935"]}, {"Citation": "Palliyage GH, Hussein N, Mimlitz M, et\u00a0al. Novel curcumin\u2010resveratrol solid nanoparticles synergistically inhibit proliferation of melanoma cells. Pharm res. 2021;38(5):851\u2010871.", "ArticleIdList": ["33982225"]}, {"Citation": "Iqubal MK, Iqubal A, Imtiyaz K, et\u00a0al. Combinatorial lipid\u2010nanosystem for dermal delivery of 5\u2010fluorouracil and resveratrol against skin cancer: delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis. Eur J Pharm Biopharm. 2021;163:223\u2010239.", "ArticleIdList": ["33864904"]}, {"Citation": "Lin M, Yao W, Xiao Y, et\u00a0al. Resveratrol\u2010modified mesoporous silica nanoparticle for tumor\u2010targeted therapy of gastric cancer. Bioengineered. 2021;12(1):6343\u20106353.", "ArticleIdList": ["PMC8806839", "34506231"]}, {"Citation": "Andres S, Pevny S, Ziegenhagen R, et\u00a0al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food res. 2018;62(1):1700447.", "ArticleIdList": ["29127724"]}, {"Citation": "Patil P, Killedar S. Formulation and characterization of gallic acid and quercetin chitosan nanoparticles for sustained release in treating colorectal cancer. J Drug Del Sci Tech. 2021;63:102523."}, {"Citation": "Iqubal MK, Khan MA, Agarwal NB, Ali J, Baboota S. Nanoformulations\u2010based advancement in the delivery of phytopharmaceuticals for skin cancer management. J Drug Deliv Sci Tech. 2021;66:102912."}, {"Citation": "Gulla S, Reddy VC, Araveti PB, et\u00a0al. Synthesis of titanium dioxide nanotubes (TNT) conjugated with quercetin and its in\u00a0vivo antitumor activity against skin cancer. J Mol Struct. 2022;1249:131556."}, {"Citation": "Manso J, Sharifi\u2010Rad J, Zam W, Fokou PVT, Martorell M, Pezzani R. Plant natural compounds in the treatment of adrenocortical tumors. Int J Endocrinol. 2021;2021:1\u201018.", "ArticleIdList": ["PMC8463247", "34567112"]}, {"Citation": "Alhakamy NA, Fahmy UA, Eldin SMB, et\u00a0al. Scorpion venom\u2010functionalized quercetin phytosomes for breast cancer management: in\u00a0vitro response surface optimization and anticancer activity against MCF\u20107 cells. Polymers. 2022;14(1):93.", "ArticleIdList": ["PMC8747200", "35012116"]}, {"Citation": "Ayala\u2010Fuentes JC, Gallegos\u2010Granados MZ, Villarreal\u2010G\u00f3mez LJ, Antunes\u2010Ricardo M, Grande D, Chavez\u2010Santoscoy RA. Optimization of the synthesis of natural polymeric nanoparticles of inulin loaded with quercetin: characterization and cytotoxicity effect. Pharmaceutics. 2022;14(5):888.", "ArticleIdList": ["PMC9147723", "35631474"]}, {"Citation": "Yadav N, Tripathi AK, Parveen A. PLGA\u2010quercetin nano\u2010formulation inhibits cancer progression via mitochondrial dependent caspase\u20103, 7 and independent FoxO1 activation with concomitant PI3K/AKT suppression. Pharmaceutics. 2022;14(7):1326.", "ArticleIdList": ["PMC9323198", "35890222"]}, {"Citation": "Askar MA, El\u2010Nashar HA, Al\u2010Azzawi MA, Rahman SSA, Elshawi OE. Synergistic effect of quercetin magnetite nanoparticles and targeted radiotherapy in treatment of breast cancer. Breast Canc: Basic Clin Res. 2022;16: 11782234221086728.", "ArticleIdList": ["PMC8961357", "35359610"]}, {"Citation": "Ghanbari\u2010Movahed M, Mondal A, Farzaei MH, Bishayee A. Quercetin\u2010and rutin\u2010based nano\u2010formulations for cancer treatment: a systematic review of improved efficacy and molecular mechanisms. Phytomedicine. 2022;97:153909.", "ArticleIdList": ["35092896"]}, {"Citation": "Elsayed AM, Sherif NM, Hassan NS, Althobaiti F, Hanafy NA, Sahyon HA. Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti\u2010breast cancer agent via regulating p53 in rat model. Int J Biol Macromol. 2021;185:134\u2010152.", "ArticleIdList": ["34147524"]}, {"Citation": "Alkahtani S, Alarifi S, Aljarba NH, Alghamdi HA, Alkahtane AA. Mesoporous SBA\u201015 silica\u2013loaded nano\u2010formulation of quercetin: a probable radio\u2010sensitizer for lung carcinoma. Dose\u2010Response. 2022;20(1):15593258211050532.", "ArticleIdList": ["PMC8777362", "35110975"]}, {"Citation": "Ramalingam V, Sathya PM, Srivalli T, Mohan H. Synthesis of quercetin functionalized wurtzite type zinc oxide nanoparticles and their potential to regulate intrinsic apoptosis signaling pathway in human metastatic ovarian cancer. Life Sci. 2022;309:121022.", "ArticleIdList": ["36206836"]}, {"Citation": "Colpan RD, Erdemir A. Co\u2010delivery of quercetin and caffeic\u2010acid phenethyl ester by polymeric nanoparticles for improved antitumor efficacy in colon cancer cells. J Microencapsul. 2021;38(6):381\u2010393.", "ArticleIdList": ["34189998"]}, {"Citation": "Davarnejad R, Layeghy K, Soleymani M, Ayazi A. Encapsulation of quercetin in a mixed Nanomicellar system to enhance its cytotoxicity against breast cancer cells. Chem Eng Tech. 2022;45(6):1100\u20101105."}, {"Citation": "Argenziano M, Arpicco S, Brusa P, et\u00a0al. Developing actively targeted nanoparticles to fight cancer. Focus on Italian Res Pharma. 2021;13(10):1538.", "ArticleIdList": ["PMC8540327", "34683830"]}, {"Citation": "Ganthala PD, Alavala S, Chella N, Andugulapati SB, Bathini NB, Sistla R. Co\u2010encapsulated nanoparticles of erlotinib and quercetin for targeting lung cancer through nuclear EGFR and PI3K/AKT inhibition. Colloids Surf B Biointerfaces. 2022;211:112305.", "ArticleIdList": ["34998178"]}, {"Citation": "Mekkawy AI, Eleraky NE, Soliman GM, Elnaggar MG, Elnaggar MG. Combinatorial therapy of letrozole\u2010and quercetin\u2010loaded Spanlastics for enhanced cytotoxicity against MCF\u20107 breast cancer cells. Pharmaceutics. 2022;14(8):1727.", "ArticleIdList": ["PMC9415400", "36015353"]}, {"Citation": "Tiwari H, Karki N, Pal M, et\u00a0al. Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: the synergistic effect of quercetin and gefitinib against ovarian cancer cells. Colloids Surf B Biointerfaces. 2019;178:452\u2010459.", "ArticleIdList": ["30921680"]}, {"Citation": "Sharma T, Singh D, Mahapatra A, Mohapatra P, Sahoo S, Sahoo SK. Advancements in clinical translation of flavonoid nanoparticles for cancer treatment. OpenNano. 2022;8:100074."}, {"Citation": "Siveen KS, Uddin S, Mohammad RM. Targeting acute myeloid leukemia stem cell signaling by natural products. Mol Canc. 2017;16:1\u201012.", "ArticleIdList": ["PMC5282735", "28137265"]}, {"Citation": "Bilia AR, Piazzini V, Risaliti L, et\u00a0al. Nanocarriers: a successful tool to increase solubility, stability and optimise bioefficacy of natural constituents. Curr Med Chem. 2019;26(24):4631\u20104656.", "ArticleIdList": ["30381065"]}, {"Citation": "Dang Y, Guan J. Nanoparticle\u2010based drug delivery systems for cancer therapy. Smart Materials in Med. 2020;1:10\u201019.", "ArticleIdList": ["PMC8455119", "34553138"]}, {"Citation": "\u00dcnal S, Akta\u015f Y, Benito JM, Bilensoy E. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: formulation development and optimization. Int J Pharm. 2020;584:119468.", "ArticleIdList": ["32470483"]}, {"Citation": "Jabri T, Imran M, Aziz A, et\u00a0al. Design and synthesis of mixed micellar system for enhanced anticancer efficacy of paclitaxel through its co\u2010delivery with naringin. Drug Dev Ind Pharm. 2019;45(5):703\u2010714.", "ArticleIdList": ["30557053"]}, {"Citation": "Parvathaneni V, Elbatanony RS, Goyal M, et\u00a0al. Repurposing Bedaquiline for effective non\u2010small cell lung cancer (NSCLC) therapy as inhalable cyclodextrin\u2010based molecular inclusion complexes. Int J Mol Sci. 2021;22(9):4783.", "ArticleIdList": ["PMC8124211", "33946414"]}, {"Citation": "Werner ME, Cummings ND, Sethi M, et\u00a0al. Preclinical evaluation of Genexol\u2010PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non\u2010small cell lung cancer. Int J Oncol Biol Phys Ther. 2013;86(3):463\u2010468.", "ArticleIdList": ["PMC3750707", "23708084"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "5"}, {"Year": "2023", "Month": "10", "Day": "24"}, {"Year": "2023", "Month": "12", "Day": "10"}, {"Year": "2024", "Month": "3", "Day": "18", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "3", "Day": "16", "Hour": "21", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "16", "Hour": "4", "Minute": "3"}, {"Year": "2024", "Month": "3", "Day": "16"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38491817", "PMC10943377", "10.1002/cam4.7010"]}}]}